Susan M. Hannum

Susan M. Hannum

Auto-generated profile, based on publicly available information

Susan M. Hannum

Johns Hopkins Bloomberg School of Public Health

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2016 in JMIR Cancer
Verified
Journal Article
Open access
KSKatherine Clegg Smith
Katherine Clegg Smith
ETElliott Tolbert
Elliott Tolbert
SHSusan M Hannum
Susan M Hannum
ARArchana Radhakrishnan
Archana Radhakrishnan
KZKelsey Zorn
Kelsey Zorn
CSClaire F Snyder
Claire F Snyder
Patient-Centered Innovations, Education and Technology for Cancer Care and Cancer Research

20 April 2023 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
SKSara C. Keller
Sara C. Keller
SHSusan M. Hannum
Susan M. Hannum
KWKimberly Weems
Kimberly Weems
OOOpeyemi Oladapo-Shittu
Opeyemi Oladapo-Shittu
ASAlejandra B. Salinas
Alejandra B. Salinas
TCthe Home Infusion CLABSI Prevention Collaborative
the Home Infusion CLABSI Prevention Collaborative
Objective: Central-line–associated bloodstream infection (CLABSI) surveillance in home infusion therapy is necessary to track efforts to reduce infections, but a standardized, validated, and feasible definition is lacking. We tested the validity of a home-infusion CLABSI surveillance definition and the feasibility and acceptability of its implementation.Design: Mixed-methods study including validation of CLABSI cases and semistructured interviews with staff applying these approaches.Setting: This study was conducted in 5 large home-infusion agencies in a CLABSI prevention collaborative across 14 states and the District of Columbia.Participants: Staff performing home-infusion CLABSI surveillance.Methods: From May 2021 to May 2022, agencies implemented a home-infusion CLABSI surveillance definition, using 3 approaches to secondary bloodstream infections (BSIs): National Healthcare Safety Program (NHSN) criteria, modified NHSN criteria (only applying the 4 most common NHSN-defined secondary BSIs), and all home-infusion–onset bacteremia (HiOB). Data on all positive blood cultures were sent to an infection preventionist for validation. Surveillance staff underwent semistructured interviews focused on their perceptions of the definition 1 and 3–4 months after implementation.Results: Interrater reliability scores overall ranged from κ = 0.65 for the modified NHSN criteria to κ = 0.68 for the NHSN criteria to κ = 0.72 for the HiOB criteria. For the NHSN criteria, the agency-determined rate was 0.21 per 1,000 central-line (CL) days, and the validator-determined rate was 0.20 per 1,000 CL days. Overall, implementing a standardized definition was thought to be a positive change that would be generalizable and feasible though time-consuming and labor intensive.Conclusions: The home-infusion CLABSI surveillance definition was valid and feasible to implement.

1 December 2017 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
SDSydney M. Dy
Sydney M. Dy
NHNebras Abu Al Hamayel
Nebras Abu Al Hamayel
SHSusan M. Hannum
Susan M. Hannum
RSRitu Sharma
Ritu Sharma
SISarina R. Isenberg
Sarina R. Isenberg
SWSallie J. Weaver
Sallie J. Weaver

11 April 2023 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
SHSusan M. Hannum
Susan M. Hannum
OOOpeyemi Oladapo-Shittu
Opeyemi Oladapo-Shittu
ASAlejandra B. Salinas
Alejandra B. Salinas
KWKimberly Weems
Kimberly Weems
JMJill Marsteller
Jill Marsteller
SKSara C. Keller
Sara C. Keller
Objectives: Access to patient information may affect how home-infusion surveillance staff identify central-line–associated bloodstream infections (CLABSIs). We characterized information hazards in home-infusion CLABSI surveillance and identified possible strategies to mitigate information hazards. Design: Qualitative study using semistructured interviews. Setting and participants: The study included 21 clinical staff members involved in CLABSI surveillance at 5 large home-infusion agencies covering 13 states and the District of Columbia. Methods: Interviews were conducted by 1 researcher. Transcripts were coded by 2 researchers; consensus was reached by discussion. Results: Data revealed the following barriers: information overload, information underload, information scatter, information conflict, and erroneous information. Respondents identified 5 strategies to mitigate information chaos: (1) engage information technology in developing reports; (2) develop streamlined processes for acquiring and sharing data among staff; (3) enable staff access to hospital electronic health records; (4) use a single, validated, home-infusion CLABSI surveillance definition; and (5) develop relationships between home-infusion surveillance staff and inpatient healthcare workers. Conclusions: Information chaos occurs in home-infusion CLABSI surveillance and may affect the development of accurate CLABSI rates in home-infusion therapy. Implementing strategies to minimize information chaos will enhance intra- and interteam collaborations in addition to improving patient-related outcomes.

12 May 2022
Verified
Report
Open access
KSKatherine Clegg Smith
Katherine Clegg Smith
YCYoungjee Choi
Youngjee Choi
ABAmanda Blackford
Amanda Blackford
JDJennifer DeSanto
Jennifer DeSanto
NMNancy Mayonado
Nancy Mayonado
CSClaire Snyder
Claire Snyder

21 January 2026 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
SHSusan Hannum
Susan Hannum
JMJill Marsteller
Jill Marsteller
AGAyse P. Gurses
Ayse P. Gurses
SCSara E. Cosgrove
Sara E. Cosgrove
ISIlya Shpitser
Ilya Shpitser
SKSara C. Keller
Sara C. Keller
Objectives: To evaluate the implementation and effectiveness of a novel home infusion central line-associated bloodstream infection (CLABSI) and home infusion-onset bloodstream infection (HiOB) dashboard and prevention toolkit. Design: Mixed methods study. Setting and Participants: Five home infusion agencies participating in the first CLABSI prevention collaborative. Methods: Agencies uploaded CLABSI and HiOB data to a comparative dashboard. The dashboard started in December 2022 and accepted retrospective data from June 2021. A CLABSI prevention toolkit was made available in June 2024. Using an interrupted time series, we present CLABSI and HiOB rates before and after dashboard and toolkit implementation. We surveyed and interviewed participants about the tools and toolkit, using directed content analysis to analyze the interviews. Results: After dashboard implementation, there was a decrease in CLABSI (−0.23/10,000 home-CVC days, 95% CI −0.28 to −0.18) and HiOB (−0.25/10,000 home-CVC days, 95% CI: −0.31 to −0.18) over time. With toolkit implementation, there was a further decrease in CLABSI (−0.17/10,000 home-CVC days, 95% CI: −0.30 to −0.044) and HiOB (−0.23/10,000 home-CVC days, 95% CI: −0.37 to −0.089) over time. Themes were associated with use of the tools (accessible, adaptable, patient-centered tools; user-friendly education to enhance understanding; barriers identified; tool mismatches; and strategies for tool delivery) and toolkit implementation (structural barriers, user-centered design, collaborative engagement and communication, toolkit used to enhance workforce competency, and concerns related to consistency). Conclusions: Implementation of a dashboard and a CLABSI prevention toolkit were each associated with both CLABSI and HiOB reduction in a collaborative of home infusion agencies.